Join Now

Category Archives: BioUtah News

Altitude Lab Announces First Cohort of Startups Close Over $50M in Seed Capital

The total capital represents the largest seed financing for life science startups in Utah’s history

| Tagged | Leave a comment

Halia Therapeutics Presented Data on Targeting the NLRP3 Inflammasome for the Treatment of Alzheimer’s Disease

Halia Therapeutics presented data today on its NLRP3 inhibitor program at today’s 10th Annual Neurodegenerative Drug Development Summit. 

| Tagged | Leave a comment

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022

| Tagged | Leave a comment

Pfizer’s $7B bet delivers phase 3 success, advancing bid to establish new drug in ulcerative colitis Arena

Pfizer’s $6.7 billion bet on Arena Pharmaceuticals has delivered a phase 3 success.

| Tagged | Leave a comment

Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Recursion reported business updates and financial results for its fourth quarter and fiscal year ending December 31, 2021.

| Tagged | Leave a comment

FierceBiotech recognizes Recursion as the #2 Biotech IPO of 2021!

FierceBiotech Special Report: The top 10 biotech IPOs of 2021

| Tagged | Leave a comment

Co-Diagnostics Reports Full Year 2021 Financial Results

Achieved Record Full Year Revenue of $97.9 Million; Strength in Sales Momentum Provides Foundation to Achieve Solid FY’22

| Tagged , | Leave a comment

WATCH THE EXIM BANK & STEP GRANT FUNDS 101 WEBINAR REPLAY

WTC UTAH HAS A RECORD $1M+ TO ADMINISTER TO UTAH SMALL BUSINESSES. Learn from World Trade Center Utah, Meridian Finance Group, and the U.S. Small Business Administration (SBA) about export programs through the Export-Import Bank of the United States (EXIM) and how State Trade Expansion Program (STEP) funds can be used for those programs as a new eligible expense.

| Leave a comment

Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board

Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board

| Tagged , | Leave a comment

Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies

Myriad to establish new Walter Gilbert Research and Innovation Center Company also cited among 2022 Top Workplaces USA National List by Energage

| Tagged | Leave a comment

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer

BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast cancer

| Tagged | Leave a comment

Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care

Company launches Precise™ Tumor test, part of a comprehensive suite combining germline, tumor and companion diagnostics in one easy-to-access solution

| Tagged | Leave a comment